FDA advisors reject MDMA therapy for PTSD, amid concerns over research

A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.

Related Keywords

Maryland ,United States ,Colorado ,Johns Hopkins University ,Jonathan Lubecky ,David Millis ,Walter Dunn ,Nick Brown ,Kim Witczak ,Paul Holtzheimer ,Melissa Barone ,Maryann Amirshahi ,Elizabeth Joniak ,Berra Yazar Klosinski ,Georgetown University ,National Center ,Institute For Clinical ,Drug Administration ,Va Maryland Health Care System ,Updated June ,Lykos Therapeutics ,Health Care ,Elizabeth Joniak Grant ,Alia Lilienstein ,Economic Review ,